Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the vital role MRNA technology played in COVID-19 vaccines. As the building ...

1. A nucleoside-modified mRNA (modRNA) influenza vaccine showed greater protection against influenza-like illness compared to a standard inactivated vaccine in adults. 2. The modRNA vaccine triggered ...

Belgian scientists have uncovered new details about how the immune system responds to vaccines. Dendritic cells, which are key immune messengers that help kick-start ...

(HealthDay News) — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated quadrivalent influenza vaccine, according to a study published in ...

In this randomized Phase III trial, investigators assigned 18,476 healthy adults between 18 and 64 years of age to receive either a quadrivalent modified mRNA influenza vaccine or a licensed ...

The "mRNA Vaccines Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The mRNA Vaccines Market is experiencing significant growth, evolving from USD 9.32 billion ...

Moderna Inc (NASDAQ:MRNA) stock is trading sharply lower on Monday afternoon as recent clinical setbacks overshadowed positive pipeline news. What To Know: The decline continues despite Moderna’s ...

In a development that could shape cancer treatment strategies, researchers have found evidence that COVID mRNA vaccines can enhance the effectiveness of cancer immunotherapy and significantly improve ...

Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...

BLOOM (TAMPA)- Dr. Kawsar Talaat, Associate Professor of Global Disease Epidemiology and Control at John’s Hopkins University, joins Casey Phillips, guest host of Bloom, guest host for Bloom, to ...